Trademark Attorney / Law Firm

Charles Valauskas – Trademark Portfolio

Charles Valauskas has filed 4 trademarks with the United States Patent and Trademark Office (USPTO). Filing records are from 2026. Of these filings, 0 are currently registered and 3 are pending. The portfolio covers 4 Nice Classification classes, with the highest concentration in Class 35 (Advertising & Business, 1 filings) and Class 42 (Computer & Scientific, 1 filings).

4 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Charles Valauskas's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademark applications has Charles Valauskas filed?

Charles Valauskas has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 pending, 1 cancelled.

What trademark classes does Charles Valauskas specialize in?

Charles Valauskas has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What is Charles Valauskas's trademark registration success rate?

Charles Valauskas has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.